Alnylam Pharmaceuticals
ALNY
$148.43
Share price
-1.07%
Change (1 day)
-21.33%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares
Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.3277% (annualized)
Shares available to borrow: 2100000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart
Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days
Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2024 to 2023
Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2024 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 Novartis NVS | 0.4081% | 0.65 M | 🇨🇭 Switzerland |
 Sanofi SNY | 0.25% | 2.2 M | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | 0.4081% | 2.6 M | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 0.2999% | 1.9 M | 🇺🇸 USA |
 Regulus Therapeutics RGLS | 10.2128% | 0.35 M | 🇺🇸 USA |
 OPKO Health
OPK | 6.0312% | 0.3 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.2809% | 10 M | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | 0.25% | 2.2 M | 🇺🇸 USA |